Skip to search formSkip to main contentSkip to account menu

Hetastarch

Known as: HYDROXYETHYL STARCH, Hetastarch [Chemical/Ingredient], HES 
A synthetic, nonionic hydroxyethyl derivative of starch used as a plasma expander when prepared in an isotonic solution. Upon intravenous… 
National Institutes of Health

Related topics

Related topics

22 relations
500 ML Hetastarch 60 MG/ML Injection500 ML Hetastarch 60 MG/ML Injection [Hespan]500 ML Hetastarch 60 MG/ML Injection [Hextend]Anuria

Narrower (6)

HAES-sterilHespanHextendPlasmasteril

Broader (1)

Hydroxyethyl Starch Derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Update on the Comparative Safety of Colloids: A Systematic Review of Clinical Studies
Objective:To provide an updated systematic review on the comparative safety of colloids based on recent clinical studies… 
Highly Cited
2001
Highly Cited
2001
Voluven®, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5
Hydroxyethyl starch (HES) solutions are effective plasma volume expanders. Impairment of coagulation occurs with large HES… 
Highly Cited
2001
Highly Cited
2001
The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery.
UNLABELLED A new hydroxyethyl starch (HES) preparation with a mean molecular weight of 130,000 daltons and a degree of… 
Highly Cited
2000
Highly Cited
2000
Cardiovascular and Metabolic Response to Acute Normovolemic Anemia: Effects of Anesthesia
BackgroundThe maintenance of adequate tissue oxygenation during acute anemia depends on an increase in both cardiac output and… 
Highly Cited
2000
Highly Cited
2000
Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight
Background: Hydroxyethyl starches (HES) are known to interfere with blood coagulation according to molecular weight, the degree… 
Highly Cited
2000
Highly Cited
2000
Acid–Base Changes Caused by 5% Albumin versus 6% Hydroxyethyl Starch Solution in Patients Undergoing Acute Normovolemic Hemodilution: A Randomized Prospective Study
BackgroundPreoperative acute normovolemic hemodilution (ANH) is an excellent model for evaluating the effects of different… 
Review
1997
Review
1997
Hydroxyethyl Starch: Safe or Not
H ydroxyethyl starch (HES) and albumin are the two colloids administered most frequently for intravascular volume expansion… 
Review
1996
Review
1996
Hemodilution in Clinical Surgery: State of the Art 1996
Abstract. Acute normovolemic hemodilution entails removal of blood from a patient either immediately before or shortly after… 
Highly Cited
1995
Highly Cited
1995
HES 200/0.5 Is not HES 200/0.5
Summary The plasma clearance of hydroxyethyl starch (HES) depends on the initial molecular weight and the degree of substitution… 
Highly Cited
1988
Highly Cited
1988
Pentastarch may cause fewer effects on coagulation than hetastarch
Hetastarch, the currently marketed preparation of hydroxyethyl starch, affects coagulation by prolonging partial thromboplastin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)